“Several negotiations are in the final phase and an official announcement will be made when the negotiations are finalised soon. These negotiations comprise collaboration in all aspects of vaccine development, like R&D, scientists exchange, fill-and-finish development (technology transfer, logistics, cold chain), including vaccine purchase (finished product), as a guarantee of access to a vaccine supply for the country,” Khairy said.
“Detailed information cannot be announced because these are non-disclosure agreements.”
Between Sinopharm, Sinovac and Cansino vaccine from China (all of which require storage 2-8C), Sinopharm is currently leading the vaccine race. Their phase III clinical trial is nearing completion and expected to be completed this month. Get ready to fly!!!
Malaysia telah memilih vaksin yang dihasilkan oleh China yang memerlukan suhu 2 hingga 4 darjah celsius sahaja kerana proses penghasilannya yang berbeza.
Malaysia telah memilih vaksin yang dihasilkan oleh china yang memerlukan suhu 2 hingga 4 darjah celsius sahaja kerana proses penghasilannya yang berbeza.
No, GI Healthcare Resources Sdn Bhd, is just fulfiling their social corporate responsibility by sponsoring 10,000 doses for emergency use of Sinopharm Vaccine.
Please go and look at the agreement between Titijaya and Sinopharm again and you will find more ‘hints’ on the grand plan. The only missing word is vaccine, which can be easily replaced by the word ‘medical product’ stated in the agreement.
If other little known companies dare to announce that they are getting in vaccines. It is almost certain that Titijaya will bring in Sinopharm vaccines to Malaysia because Titijaya and Sinopharm are already existing business partner with so many plans ahead.
What Titijaya has signed with Sinopharm is a 5 formal years agreement and Malaysia government also sign a 5 years agreement with China. So what does this tell you? It means what Titijaya is doing will be according to the government’s plan.
In short, just relax and wait for budget approval and more details will be announced in due course. Have faith in Tan Sri Lim and his team from Titijaya Medical.
Another point to take note, judging from the price movement over the last several weeks, it seems that someone has been placing big road block (especially today) at the sell side to prevent price from moving up and their intention is to let nonbelievers and weak holders to sell them cheaply.
My advice is just ignore them. You don’t have to chase the price and just queue at buy side together with them.
Vaccines are coming so price won’t stay low for long.
The main, immediate focus of the collaboration will be the supply of equipment such as personal protection equipment (PPE), RT-PCR (real-time reverse transcription polymerase chain reaction) test kits, rapid test kits, mobile test labs and other necessary equipment needed to combat Covid-19.
Under the agreement, Titijaya said TRSB and SMEQ will collaborate to develop the business by leveraging on the supply and value chain of Sinopharm Group and SMEQ in China, as well as the networks of TRSB and Sinopharm Group.
“For other businesses of Sinopharm Group not within the scope of business of SMEQ, SMEQ will assist TRSB to develop such scope of business by coordinating with Sinopharm Group to accommodate the demands of TRSB,” Titijaya said.
TRSB, meanwhile, will be responsible to provide infrastructure, land and facilities for medical industry operators recommended by Sinopharm Group or SMEQ.
Aiyo Alibba Scenery...someone at here want to Tiew Nei leh...you better hide lah ..go where also make ppl angry ..want to tiew nei wo.....lol...wakakaka...kikiki
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Maridien2
1,084 posts
Posted by Maridien2 > 2020-11-15 21:35 | Report Abuse
if got won't be this price liao